|Frontotemporal dementia (FTD) or frontotemporal degenerations refers to a group of disorders caused by progressive nerve cell loss in the brain's frontal lobes (the areas behind your forehead) or its temporal lobes (the regions behind your ears).|
The nerve cell damage caused by frontotemporal dementia leads to loss of function in these brain regions, which variably cause deterioration in behavior and personality, language disturbances, or alterations in muscle or motor functions.
There are a number of different diseases that cause frontotemporal degenerations. The two most prominent are 1) a group of brain disorders involving the protein tau and 2) a group of brain disorders involving the protein called TDP43. For reasons that are not yet known, these two groups have a preference for the frontal and temporal lobes that cause dementia.
The disorders grouped under FTD fall into three subtypes (discussed below).
FTD used to be called Pick's disease after Arnold Pick, a physician who in 1892 first described a patient with distinct symptoms affecting language. Some doctors still use the term "Pick's disease." Other terms you may see used to describe FTD include frontotemporal disorders, frontotemporal degenerations and frontal lobe disorders.
Behavior variant frontotemporal dementia (bvFTD). This condition is characterized by prominent changes in personality, interpersonal relationships and conduct that often occur in people in their 50s and 60s, but can develop as early as their 20s or as late as their 80s. In bvFTD, the nerve cell loss is most prominent in areas that control conduct, judgment, empathy and foresight, among other abilities.
Primary progressive aphasia (PPA). This is the second major form of frontotemporal degeneration that affects language skills, speaking, writing and comprehension. PPA normally comes on in midlife, before age 65, but can occur in late life also. The two most distinctive forms of PPA have somewhat different symptoms:
Disturbances of motor (movement or muscle) function. There are three disorders that are a part of the frontotemporal degeneration spectrum that produce changes in muscle or motor functions with or without behavior (bvFTD) or language (PPA) problems.
Both bvFTD and PPA are far less common than Alzheimer’s disease in those over age 65 years. However, in the 45 to 65 age range, bvFTD and PPA are nearly as common as younger-onset Alzheimer’s. Only rough estimates are available, but there may be 50,000 to 60,000 people with bvFTD and PPA in the United States, the majority of whom are between 45 and 65 years of age.
Sign up for our weekly e-newsletter
Stay up-to-date on the latest advances in Alzheimer's and dementia treatments, care and research. Subscribe now
The diagnosis of bvFTD and PPA are based on expert evaluation by a doctor who is familiar with these disorders. The type of problems experienced by the patient and the results of neurological exams are the core of the diagnosis. Brain scans such as magnetic resonance imaging (MRI) and glucose positron emission scans are very helpful additional tests, but they must be interpreted in the context of the patient’s history and neurological exam.
Frontotemporal degenerations are inherited in about a third of all cases. Genetic counseling and testing is available now in individuals with family histories of frontotemporal degenerations. There are no known risk factors for any frontotemporal degenerations except for a family history or a similar disorder.
There are no specific treatments for any of the frontotemporal subtypes. There are medications that can reduce agitation, irritability and/or depression. These treatments should be used to help improve quality of life.
FTD inevitably gets worse over time and the speed of decline differs from person to person. For many years, individuals with FTD show muscle weakness and coordination problems, leaving them wheelchair- or bedbound. These muscle issues can cause problems swallowing, chewing, moving and controlling bladder and/or bowels. Eventually people with frontotemporal degenerations die because of the physical changes that can cause skin, urinary tract and/or lung infections.